Select a community
All Communities
Home > Community Treatment Reports > Apo-Sertraline (sertraline) Treatment Report
What is Apo-Sertraline?

Apo-Sertraline® is a Canadian brand name for sertraline a selective serotonin reuptake inhibitor (SSRI) antidepressant, is used in the treatment of major depression; obsessive-compulsive disorder; panic disorder; post-traumatic stress disorder; premenstrual dysphoric disorder; and social anxiety.

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Depression 2 0
Anxiety 1 0
Major Depressive Disorder 1 0
pain,depression,fatigue 1 0
anxiety, depression, confusion, falling down 1 0

Mouse over the table for more information

Dosages

  50 mg daily 100 mg daily 150 mg daily 200 mg daily
  1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Apo-Sertraline (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other
1 100% Other: 100%

See all 1 patient who’ve stopped taking Apo-Sertraline

Currently Taking Apo-Sertraline

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
1
2
0
1

Stopped Taking Apo-Sertraline

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
1
0
0
0
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
0 0%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
0 0%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 22, 2009.